HUTCHMED (China) (HMDCF) Shareholder's Equity Growth (1y) (2015 - 2025)
HUTCHMED (China) (HMDCF) Shareholder's Equity Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | HUTCHMED (China) | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 65.15% |
| Jun 30, 2024 | -6.00% |
| Jun 30, 2023 | -6.08% |
| Dec 31, 2022 | -38.73% |
| Jun 30, 2022 | -15.97% |
| Dec 31, 2021 | 100.31% |
| Jun 30, 2021 | 176.18% |
| Dec 31, 2020 | 65.85% |
| Dec 31, 2019 | -23.98% |
| Dec 31, 2018 | -14.94% |
| Dec 31, 2017 | 137.13% |
| Jun 30, 2017 | 6.19% |
| Dec 31, 2016 | 99.52% |
| Dec 31, 2015 | 79.70% |